Estalis Sequi

Valsts: Jaunzēlande

Valoda: angļu

Klimata pārmaiņas: Medsafe (Medicines Safety Authority)

Aktīvā sastāvdaļa:

Estradiol 4.33mg equivalent to 50 µg/24h oestradiol; Estradiol hemihydrate 0.62mg equivalent to oestradiol 50 µg/24 hours;  ; Norethisterone acetate 2.7mg equivalent to norethisterone acetate 140 µg/24 hours;  

Pieejams no:

Novartis New Zealand Ltd

SNN (starptautisko nepatentēto nosaukumu):

Estradiol 4.33 mg (equivalent to 50 µg/24h oestradiol)

Deva:

50 + 50/140

Zāļu forma:

Transdermal patch

Kompozīcija:

Active: Estradiol 4.33mg equivalent to 50 µg/24h oestradiol Excipient: 1,3-Butylene glycol Acrylic adhesive Bentonite Dipropylene glycol Ethylenevinylacetate copolymer Lecithin Liquid paraffin Oleic acid Polyisobutylene Synthetic adhesive Active: Estradiol hemihydrate 0.62mg equivalent to oestradiol 50 µg/24 hours   Norethisterone acetate 2.7mg equivalent to norethisterone acetate 140 µg/24 hours   Excipient: Acrylic adhesive Dipropylene glycol Oleic acid Povidone Silicone adhesive

Vienības iepakojumā:

Sachet, aluminium foil, laminate paper/PE/Al/PE, 8 patches

Klase:

Prescription

Receptes veids:

Prescription

Ražojis:

NV Organon

Produktu pārskats:

Package - Contents - Shelf Life: Sachet, aluminium foil, laminate paper/PE/Al/PE - 8 patches - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 6 months opened stored at or below 25°C

Autorizācija datums:

2002-07-12